XML 47 R29.htm IDEA: XBRL DOCUMENT v3.25.1
Licensed Rights and Other Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2024
Licensed Rights and Other Intangible Assets [Abstract]  
Schedule of License Rights and Other Intangible Assets, Net

The following provides information about our license rights and other intangible assets, net (in thousands):

  

   As of December 31, 2024   As of December 31, 2023 
   Gross           Gross         
   Carrying   Accumulated       Carrying   Accumulated     
   Amount   Amortization   Net   Amount   Amortization   Net 
Intangible assets subject to amortization:                        
Hormone therapy drug patents  $5,766   $2,058   $3,708   $6,818   $1,871   $4,947 
Hormone therapy drug patents applied and pending approval   304    —    304    842    —    842 
Intangible assets subject to amortization   6,070    2,058    4,012    7,660    1,871    5,789 
Intangible assets not subject to amortization:                              
Trademarks/trade name rights   309    —    309    309    —    309 
Intangible assets, net  $6,379   $2,058   $4,321   $7,969   $1,871   $6,098 
Schedule of Intangible Assets Subject to Amortization

Our intangible assets subject to amortization are expected to be amortized as follows (in thousands):

 

Year ending December 31,    
2025  $384 
2026   384 
2027   384 
2028   385 
2029   384 
Thereafter   1,787 
Total  $3,708